VBWG

FEATURED

VBWG QuickTakes

Robert Giugliano, MD

Brigham and Women’s Hospital
Boston MA
Update on the Metamorphosis Occurring in Lipid Therapy Today

Sotirios Tsimikas, MD

UC San Diego
School of Medicine
La Jolla, CA
Therapeutic Targeting of LP(a), APOC-III, and ATP-Citrate Lyase for CVD

Howard Weintraub, MD

NYU
School of Medicine
PCSK9 Rejections: Techniques for Boosting Insurance Approvals

C. Noel Bairey Merz, MD

Cedars-Sinai Heart Institute
What Does SPIRE 1&2 Add to the Lipid Hypothesis


DOWNLOADABLE SLIDES

Core Curriculum

Progress and Promise in RAAS Blockade

View/Download individual slides (82 Slides)

Core Curriculum

Leading the Way in Cardiovascular Regenerative Medicine

View/Download individual slides (54 Slides)

Core Curriculum

Vascular Dysfunction: Sequelae of Acute Hypertension

View/Download individual slides (84 Slides)

Core Curriculum

Myocardial Ischemia Redefined: Optimal Care in CAD

View/Download individual slides (90 Slides)

Core Curriculum

Hyperglycemia and Acute Coronary Syndromes

View/Download individual slides (84 Slides)

Core Curriculum

Contemporary Management of Cardiometabolic Risk

View/Download individual slides (105 Slides)
More slides >

MEETING PRESENTATIONS

Will Incretin Therapy Change Obesity and Prediabetes Management?

Sanjay Rajagopalan, MD, FACC
Case Western Reserve University School of Medicine
Cleveland, OH

Time to Start Prescribing Diabetes Agents: A Cardiologists Call to Action

David H. Fitchett, MD, FACC
University of Toronto
Toronto, ON, Canada

Regression of Coronary Atherosclerosis: Current Evidence and Future Perspectives

Stephen J. Nicholls, MBBS, PhD, FACC
University of Adelaide
Adelaide, Australia

Therapeutic Targeting of LP(a), APOC-III, and ATP-Citrate Lyase for Cardiovascular Disease

Sotirios Tsimikas, MD, FACC
UC San Diego School of Medicine
La Joila, CA

Aspirin: How Important is Platelet Resistance?

Jawahar L. Mehta, MD, PhD, FACC
University of Arkansas for Medical Sciences
Little Rock, AR

Cardiorenal Disorders: Recent Advances, Novel Therapies

Peter A. McCullough, MD, MPH
Baylor Heart and Vascular Institute
Dallas, TX

Using TAVR in Lower and Lower Risk Patients.

Ron Waksman, MD
Washington Hospital Center
Washington, DC

Lipids 2016: Update on the Metamorphosis Occurring in Lipid Therapy Today.

Robert P. Giugliano, MD
TIMI Study Group
Boston, MA  

Benefits and Limitations of Antiplatelet Therapy. How Can We Advance the Field?

Paul A. Gurbel, MD
Johns Hopkins University School of Medicine
Baltimore, MD 
More MEETING PRESENTATIONS>

Continuing Education

PREVIOUS CONFERENCES

 

VBWG Meeting at ACC
March 16, 2017
Washington, DC
AGENDA - VIEW PRESENTATIONS


VBWG Global Chapter Meeting at AHA
November 12, 2016
New Orleans, LA
AGENDA - VIEW PRESENTATIONS


VBWG US Chapter Meeting at ACC
April 1, 2016
Chicago, IL
AGENDA - VIEW PRESENTATIONS


VBWG Global Chapter Meeting
November 7, 2015
Orlando, FL
AGENDA - VIEW PRESENTATIONS

VBWG US Chapter Meeting
March 13, 2015
San Diego, CA
AGENDA - VIEW PRESENTATIONS


VBWG Global Chapter Meeting
November 15, 2014
Chicago, IL
AGENDA - VIEW PRESENTATIONS

VBWG US Chapter Meeting
March 28, 2014
Washington, DC
AGENDA - VIEW PRESENTATIONS

VBWG Global Chapter Meeting
November 16, 2013
Dallas, TX
AGENDA - VIEW PRESENTATIONS

 
More education >

Monograph

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.
More monographs >